Search research articles
Contact Us
Filters
Showing results (721-730 of 1,159) with videos related to
Page
of 116
Sort By:
Therapeutic Advances in Neurological Disorders
|
December 25, 2010
A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS)
Gina M Remington, Katherine Treadaway, Teresa Frohman, et al.
Brain : a Journal of Neurology
|
October 21, 2017
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
Maria A Rocca, Maria Pia Sormani, Marco Rovaris, et al.
Sleep Medicine
|
June 17, 2025
The dual effect of cholesterol on cognitive functions in REM sleep behavior disorder: A pilot study
Alessandra Castelnuovo, Sara Marelli, Salvatore Mazzeo, et al.
Archives of Neurology
|
September 16, 2009
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis
Massimiliano Calabrese, Federica Agosta, Francesca Rinaldi, et al.
Human Brain Mapping
|
September 12, 2015
Brain structural and functional connectivity in Parkinson's disease with freezing of gait
Elisa Canu, Federica Agosta, Elisabetta Sarasso, et al.
Journal of Neurology
|
July 9, 2020
Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis
Christian Lunetta, Andrea Lizio, Francesca Gerardi, et al.
Journal of Neurology
|
July 12, 2020
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report
Elisa Canu, Valentina Bessi, Davide Calderaro, et al.
Journal of Neurology
|
October 1, 2025
Data-driven subtypes of subjective cognitive decline: neuropsychological profiles, Alzheimer's disease biomarkers, and clinical trajectories
Salvatore Mazzeo, Sara Boveri, Elisa Bortolin, et al.
Journal of Neurology
|
September 16, 2023
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study
Massimo Filippi, Luigi Grimaldi, Antonella Conte, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
December 9, 2014
The El Escorial criteria: strengths and weaknesses
Federica Agosta, Ammar Al-Chalabi, Massimo Filippi, et al.
Page
of 116
Search research articles
Search
Showing results (721-730 of 1,159) with videos related to
Sort By:
Page
of 116
Therapeutic Advances in Neurological Disorders
|
December 25, 2010
A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS)
Gina M Remington, Katherine Treadaway, Teresa Frohman, et al.
Brain : a Journal of Neurology
|
October 21, 2017
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
Maria A Rocca, Maria Pia Sormani, Marco Rovaris, et al.
Sleep Medicine
|
June 17, 2025
The dual effect of cholesterol on cognitive functions in REM sleep behavior disorder: A pilot study
Alessandra Castelnuovo, Sara Marelli, Salvatore Mazzeo, et al.
Archives of Neurology
|
September 16, 2009
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis
Massimiliano Calabrese, Federica Agosta, Francesca Rinaldi, et al.
Human Brain Mapping
|
September 12, 2015
Brain structural and functional connectivity in Parkinson's disease with freezing of gait
Elisa Canu, Federica Agosta, Elisabetta Sarasso, et al.
Journal of Neurology
|
July 9, 2020
Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis
Christian Lunetta, Andrea Lizio, Francesca Gerardi, et al.
Journal of Neurology
|
July 12, 2020
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report
Elisa Canu, Valentina Bessi, Davide Calderaro, et al.
Journal of Neurology
|
October 1, 2025
Data-driven subtypes of subjective cognitive decline: neuropsychological profiles, Alzheimer's disease biomarkers, and clinical trajectories
Salvatore Mazzeo, Sara Boveri, Elisa Bortolin, et al.
Journal of Neurology
|
September 16, 2023
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study
Massimo Filippi, Luigi Grimaldi, Antonella Conte, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
December 9, 2014
The El Escorial criteria: strengths and weaknesses
Federica Agosta, Ammar Al-Chalabi, Massimo Filippi, et al.
Page
of 116